Abonneer je op onze nieuwsbrief om op de hoogte te blijven
Klik hier
  • BLS

Veiligheidsgids: Asbest

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Gerelateerde artikelen

november 15, 2022 Expoprotection 2022

BLS è a Expoprotection 2022 Parigi (Francia), 15-17 novembre 2022 BLS è arrivata a Parigi all'evento internazionale dedicato a tutti i mercati della gestione del rischio. Vieni a trovarci. Siamo allo stand 1T062.     La fiera Expoprotection 2022 ospita quasi 800 espositori e oltre 20.000 acquirenti e progettisti professionisti. Questo evento è un'opportunità per incontrare i project manager della […]

Link
april 5, 2023 Samenwerking BLS & Yamaha Motor Racing

BLS e Yamaha Motor Racing ancora insieme! Siamo orgogliosi di aver rinnovato la nostra partnership con Yamaha Motor Racing e di proteggere il team Monster Energy Yamaha MotoGP.  Per il secondo anno consecutivo, BLS Group scende in pista al fianco di Yamaha Motor Racing come partner ufficiale. Per tutta la stagione 2023, infatti, il Team […]

Link
maart 2, 2020 Verschil tussen maskers

Wat zijn de verschillende soorten maskers en waarin verschillen ze? Naast de zogenaamde chirurgische maskers zijn er ook FFP1, FFP2 en FFP3, met of zonder ventiel. Maar wat zijn de verschillen tussen deze drie soorten maskers? Chirurgische maskers zijn medische hulpmiddelen die dienen om zichzelf en [...]...

Link
Abonneer op onze nieuwsbrief
Ontvang updates over onze evenementen, catalogusnieuws en aankomende initiatieven.
Abonneren

Neem contact op

Schrijf ons voor al je wensen, we nemen binnen 48 uur contact met je op.
Informatie aanvragen

BLS S.R.L.
Eenpersoonsbedrijf
via dei Giovi, 41 - 20032 Cormano (MI) - Italië
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacybeleid - Cookiebeleid

Geregistreerd kantoor
via dei Giovi, 41 - 20032 Cormano (MI) - Italië
Aandelenkapitaal: 600.000,00 euro i.v.
C.C.I.A. - R.E.A.: MI 1186898
BTW-nr.: IT12296780153
Fiscaal nummer en inschrijving in het handelsregister van Milaan: 07822320151

BLS IERLAND / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spanje
BLS NOORDWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - Nederland
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazilië
BLS DUITSLAND / Dünner Straße 249 D-41066 Mönchengladbach - Duitsland
BLS FRANKRIJK / 18 Porte du Grand Lyon 01700 Neyron - Frankrijk

kruismenuchevron-donskruiscirkel